Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Prime Medicine, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
Revenues0.00.05.2
            Revenue growth -100.0% 
Cost of goods sold0.00.00.0
Gross profit0.00.05.2
            Gross margin  100.0%
Research and development86.770.63.0
General and administrative29.813.93.2
EBIT-116.5-84.5-0.9
            EBIT margin  -17.9%
Pre-tax income-123.7-166.30.3
Income taxes-0.9-0.51.9
            Tax rate0.8%0.3%576.2%
Net income-142.0-184.1-5.1
            Net margin  -97.0%
 
Diluted EPS($4.19)($14.19)($1.91)
Shares outstanding (diluted)33.913.02.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy